Header cover image

Japanese Pharmaceuticals & Biotech Your first investment

Results

9

1 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

9 companies

Chugai Pharmaceutical

Market Cap: JP¥11.6t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

New

4519

JP¥7,069.00

7D

-3.2%

1Y

-4.6%

Otsuka Holdings

Market Cap: JP¥6.0t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

4578

JP¥11,505.00

7D

4.9%

1Y

59.0%

Astellas Pharma

Market Cap: JP¥4.1t

Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.

4503

JP¥2,295.50

7D

5.5%

1Y

54.3%

Shionogi

Market Cap: JP¥2.6t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

4507

JP¥3,070.00

7D

6.7%

1Y

21.4%

Kyowa Kirin

Market Cap: JP¥1.4t

Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.

4151

JP¥2,703.00

7D

2.9%

1Y

5.4%

Ono Pharmaceutical

Market Cap: JP¥1.2t

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

4528

JP¥2,491.50

7D

3.6%

1Y

49.5%

Santen Pharmaceutical

Market Cap: JP¥650.0b

Engages in the research and development, manufacturing, and marketing of pharmaceuticals and medical devices in Japan, China, Asia, Europe, the Middle East, Africa, and internationally.

4536

JP¥2,020.50

7D

1.7%

1Y

21.5%

Tsumura

Market Cap: JP¥301.5b

Engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally.

4540

JP¥4,045.00

7D

4.8%

1Y

9.9%

Nippon Shinyaku

Market Cap: JP¥239.3b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

4516

JP¥3,550.00

7D

-11.7%

1Y

9.7%